Co-Diagnostics, Inc. (CODX)
USD 0.33
(2.17%)
USD 0.33
(2.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 103.64 Million USD | -15.79% |
| 2022 | 123.08 Million USD | -23.09% |
| 2021 | 160.03 Million USD | 124.65% |
| 2020 | 71.23 Million USD | 3115.65% |
| 2019 | 2.21 Million USD | 42.63% |
| 2018 | 1.55 Million USD | -66.69% |
| 2017 | 4.66 Million USD | 259.8% |
| 2016 | 1.29 Million USD | 249.35% |
| 2015 | 370.93 Thousand USD | 42.75% |
| 2014 | 259.84 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 86.67 Million USD | -16.38% |
| 2024 Q2 | 80.7 Million USD | -6.89% |
| 2023 Q3 | 108.68 Million USD | -3.65% |
| 2023 Q1 | 116.99 Million USD | -4.95% |
| 2023 FY | 103.64 Million USD | -15.79% |
| 2023 Q2 | 112.8 Million USD | -3.59% |
| 2023 Q4 | 103.64 Million USD | -4.63% |
| 2022 Q2 | 160.84 Million USD | -6.02% |
| 2022 FY | 123.08 Million USD | -23.09% |
| 2022 Q1 | 171.15 Million USD | 6.95% |
| 2022 Q4 | 123.08 Million USD | -16.74% |
| 2022 Q3 | 147.84 Million USD | -8.08% |
| 2021 Q3 | 105.35 Million USD | 13.55% |
| 2021 FY | 160.03 Million USD | 124.65% |
| 2021 Q1 | 81.11 Million USD | 13.87% |
| 2021 Q2 | 92.78 Million USD | 14.39% |
| 2021 Q4 | 160.03 Million USD | 51.89% |
| 2020 FY | 71.23 Million USD | 3115.65% |
| 2020 Q1 | 20.48 Million USD | 824.48% |
| 2020 Q2 | 36.42 Million USD | 77.84% |
| 2020 Q3 | 54.65 Million USD | 50.05% |
| 2020 Q4 | 71.23 Million USD | 30.35% |
| 2019 Q4 | 2.21 Million USD | -41.88% |
| 2019 FY | 2.21 Million USD | 42.63% |
| 2019 Q3 | 3.81 Million USD | -28.32% |
| 2019 Q2 | 5.31 Million USD | -13.13% |
| 2019 Q1 | 6.12 Million USD | 294.12% |
| 2018 Q2 | 1.96 Million USD | -40.81% |
| 2018 FY | 1.55 Million USD | -66.69% |
| 2018 Q3 | 2.71 Million USD | 37.77% |
| 2018 Q4 | 1.55 Million USD | -42.76% |
| 2018 Q1 | 3.32 Million USD | -28.64% |
| 2017 FY | 4.66 Million USD | 259.8% |
| 2017 Q4 | 4.66 Million USD | -22.96% |
| 2017 Q2 | 467.58 Thousand USD | -40.55% |
| 2017 Q1 | 786.54 Thousand USD | -39.3% |
| 2017 Q3 | 6.05 Million USD | 1194.36% |
| 2016 Q3 | 284.64 Thousand USD | 0.0% |
| 2016 Q4 | 1.29 Million USD | 355.24% |
| 2016 FY | 1.29 Million USD | 249.35% |
| 2016 Q1 | - USD | -100.0% |
| 2015 Q4 | 370.93 Thousand USD | 0.0% |
| 2015 FY | 370.93 Thousand USD | 42.75% |
| 2014 FY | 259.84 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -230.446% |
| BrainsWay Ltd. | 62.97 Million USD | -64.593% |
| Cerus Corporation | 197.74 Million USD | 47.586% |
| Envoy Medical, Inc. | 7.64 Million USD | -1256.646% |
| electroCore, Inc. | 16.38 Million USD | -532.5% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -1247.474% |
| IceCure Medical Ltd | 16.41 Million USD | -531.613% |
| Inogen, Inc. | 326.19 Million USD | 68.225% |
| OrthoPediatrics Corp. | 449.58 Million USD | 76.946% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -280.08% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -525.174% |
| MaxCyte, Inc. | 268.27 Million USD | 61.365% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1180.026% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2753.803% |
| Orthofix Medical Inc. | 925.31 Million USD | 88.799% |
| PAVmed Inc | 33.11 Million USD | -212.955% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 27.747% |
| RxSight, Inc. | 182.55 Million USD | 43.222% |
| Sight Sciences, Inc. | 166.65 Million USD | 37.806% |
| SI-BONE, Inc. | 230.42 Million USD | 55.019% |
| TELA Bio, Inc. | 78.04 Million USD | -32.8% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 58.855% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -865.962% |
| Acutus Medical, Inc. | 53.96 Million USD | -92.083% |
| Talis Biomedical Corporation | 98.34 Million USD | -5.397% |
| Spectral AI, Inc. | 10.69 Million USD | -869.395% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 52.596% |
| CVRx, Inc. | 115.22 Million USD | 10.051% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -76.689% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -3227.105% |
| Bioventus Inc. | 810.91 Million USD | 87.218% |
| Venus Concept Inc. | 93.65 Million USD | -10.671% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -302.907% |
| LivaNova PLC | 2.42 Billion USD | 95.734% |
| 908 Devices Inc. | 202.98 Million USD | 48.937% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 87.128% |
| Nemaura Medical Inc. | 14.56 Million USD | -611.708% |
| NeuroPace, Inc. | 107.65 Million USD | 3.719% |
| LENSAR, Inc. | 69.58 Million USD | -48.951% |
| Apyx Medical Corporation | 79.24 Million USD | -30.802% |
| Cutera, Inc. | 346.29 Million USD | 70.069% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -146.686% |
| BioSig Technologies, Inc. | 1.79 Million USD | -5664.612% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 61.702% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -142.957% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.259% |
| Axonics, Inc. | 719.92 Million USD | 85.603% |
| Outset Medical, Inc. | 313.8 Million USD | 66.97% |
| IRIDEX Corporation | 34.43 Million USD | -200.987% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 74.39% |
| IRadimed Corporation | 92.15 Million USD | -12.47% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1872.739% |
| INVO Bioscience, Inc. | 20.88 Million USD | -396.212% |
| Telesis Bio, Inc. | 70.41 Million USD | -47.204% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 32.741% |
| Varex Imaging Corporation | 1.24 Billion USD | 91.706% |
| Quipt Home Medical Corp. | 247.4 Million USD | 58.107% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1013.295% |
| Pulmonx Corporation | 178.95 Million USD | 42.08% |
| Dynatronics Corporation | 25.94 Million USD | -299.559% |
| Modular Medical, Inc. | 13.8 Million USD | -650.69% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -866.232% |
| Semler Scientific, Inc. | 78.06 Million USD | -32.771% |
| InMode Ltd. | 863.28 Million USD | 87.994% |
| Bruker Corporation | 4.24 Billion USD | 97.561% |
| Cytosorbents Corporation | 53.26 Million USD | -94.605% |
| DexCom, Inc. | 6.26 Billion USD | 98.345% |
| Align Technology, Inc. | 6.08 Billion USD | 98.296% |
| Viveve Medical, Inc. | 25.91 Million USD | -299.984% |
| ZimVie Inc. | 1.2 Billion USD | 91.401% |
| Movano Inc. | 9.42 Million USD | -1000.178% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 79.173% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2753.803% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -76.689% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 89.12% |
| Profound Medical Corp. | 43.68 Million USD | -137.254% |
| Insulet Corporation | 2.58 Billion USD | 95.995% |
| enVVeno Medical Corporation | 48.63 Million USD | -113.113% |
| Surmodics, Inc. | 185.73 Million USD | 44.195% |
| iCAD, Inc. | 41.41 Million USD | -150.248% |
| Nuwellis, Inc. | 9.77 Million USD | -960.877% |
| Biotricity, Inc. | 5.94 Million USD | -1644.141% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 76.071% |
| Aethlon Medical, Inc. | 8.24 Million USD | -1156.948% |
| InspireMD, Inc. | 47.64 Million USD | -117.551% |
| PAVmed Inc. | 33.11 Million USD | -212.955% |
| BIOLASE, Inc. | 35.1 Million USD | -195.284% |
| Beyond Air, Inc. | 56.96 Million USD | -81.963% |
| FONAR Corporation | 214.24 Million USD | 51.622% |
| AxoGen, Inc. | 196.82 Million USD | 47.341% |
| Vivani Medical, Inc. | 45.79 Million USD | -126.32% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 63.172% |
| Inari Medical, Inc. | 674.23 Million USD | 84.627% |
| UFP Technologies, Inc. | 404.13 Million USD | 74.353% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -342.966% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -990.671% |
| Tenon Medical, Inc. | 6.34 Million USD | -1533.534% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1001.815% |
| AdaptHealth Corp. | 4.61 Billion USD | 97.756% |
| Sintx Technologies, Inc. | 15.36 Million USD | -574.57% |
| NanoVibronix, Inc. | 6.67 Million USD | -1453.008% |
| Quanterix Corporation | 425.01 Million USD | 75.613% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1013.295% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -92.916% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 94.064% |
| TransMedics Group, Inc. | 706.04 Million USD | 85.32% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -64.02% |
| NeuroMetrix, Inc. | 21.42 Million USD | -383.783% |
| Hyperfine, Inc. | 94.19 Million USD | -10.031% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 61.418% |
| Biomerica, Inc. | 9.25 Million USD | -1020.032% |
| Bone Biologics Corporation | 3.73 Million USD | -2672.988% |
| AVITA Medical, Inc. | 144.33 Million USD | 28.192% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -2028.932% |
| Silk Road Medical, Inc | 265.3 Million USD | 60.933% |